The fragile beauty of bone – a perspective on fracture risk assessment in clinical practice: a case report
Authors:
Killinger Zdenko
Authors‘ workplace:
V. interná klinika LF UK a UNB, Nemocnica Ružinov, Bratislava
Published in:
Clinical Osteology 2024; 29(4): 143-146
Category:
Overview
In Blahoš’s lecture, the author points out several aspects of bone quality and the possibilities of their use, not only when determining the risk of fracture, but also when deciding on the need for anti-porotic therapy. Briefly documents the development of diagnostic methods and therapeutic approaches in the last 30 years of Slovak osteology. Author focused on the role of bone densitometry in the diagnostic and therapeutic algorithm and progress in the position of DXA in real practice in the Slovak Republic in the given period. In conclusion, the author on a specific case report pointed out how individual bone quality parameters can influence the decision on the need for anti-porotic treatment.
Keywords:
bone densitometry – bone quality – fracture risk
Sources
Payer J, Killinger Z et al. Osteoporóza. Herba: Bratislava 2012. ISBN 978–80–89171–94–1.
Lewiecki EM, Laster AJ. Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. J Clin Endocrinol Metab 2006; 91(11): 4215–4222. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2006–1178>.
Faulkner KG, Cummings SR, Black D et al. Simple measurement of femoral geometry predicts hip fracture: the study of osteoporotic fractures. J Bone Miner Res 1993; 8: 1211–1217. Dostupné z DOI: <http://dx.doi.org/10.1002/jbmr.5650081008>.
Hans D, Goertzen AL, Krieg M-A et al. Bone Micro-Architecture Assessed by TBS Predicts Osteoporotic Fractures Independent of Bone Density: The Manitoba Study. J Bone Miner Res 2011; 26: 2762–2769. Dostupné z DOI: <http://dx.doi.org/10.1002/jbmr.499>.
Krueger D, Fidler E, Libber J et al. Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women. J Clin Densitom 2014; 17(1): 60–65. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jocd.2013.05.001>.
Watts NB. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice. J Womens Health (Larchmt) 2011; 20(4): 525–531. Dostupné z DOI: <http://dx.doi.org/10.1089/jwh.2010.2294>.
Kanis JA, McCloskey EV, Harvey NC et al. The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis. Osteoporos Int 2023; 34(1): 1–9. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198–022–06567–9>.
Pikner R, Palička V, Rosa J et al. Markery kostního obratu u osteoporózy: společné stanovisko k jejich využití Společnosti pro metabolická onemocnění skeletu České lékařské společnosti J. E. Purkyně (SMOS ČLS JEP) a České společnosti klinické biochemie České lékařské společnosti J. E. Purkyně (ČSKB ČLS JEP). Clin Osteol 2020; 25(2): 65–82.
Colloca L, Miller F. The Nocebo Effect and Its Relevance for Clinical Practice. Psychosom Med 2011; 73(7): 598–603. Dostupné z DOI: <http://dx.doi.org/10.1097/PSY.0b013e3182294a50>.
Payer J, Killinger Z, Ivana Sulková et al. Therapeutic adherence to bisphosphonates. Biomed Pharmacother 2007; 61(4): 191–193. Dostupné z DOI: <http://dx.doi.org/10.1016/j.biopha.2007.02.003>.
Labels
Clinical biochemistry Paediatric gynaecology Paediatric radiology Paediatric rheumatology Endocrinology Gynaecology and obstetrics Internal medicine Orthopaedics General practitioner for adults Radiodiagnostics Rehabilitation Rheumatology Traumatology OsteologyArticle was published in
Clinical Osteology
2024 Issue 4
Most read in this issue
- Charcot's osteoarthropathy or Sudeck's Syndrome? A case report
- Steroid contraception – the influence on bone metabolism
- Osteoporosis and liver diseases
- What's (new) in the guidelines of the osteological societies of the German-speaking countries published in 2023